Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R.   Perry Caroline M.   Robinson Dean M.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

Cardiovascular drug use and differences in the incidence of cardiovascular mortality in elderly Serbian men

By Hommerson Paul   Nedeljkovic Srecko   Klungel Olaf   Boer Anthonius   Ostojic Miodrag   Grujic Miodrag   Vojvodic Ni   Bloemberg Bennie   Kromhout Daan  

Pharmacy World and Science, Vol. 27, Iss. 2, 2005-04 ,pp. : 124-128

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

By Fisher Stacy D.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 383-394

Adis International

Access to resources Recommend Favorite

Maternal drug use in early pregnancy and infant cardiovascular defect

By Kallen B.A.J.   Otterblad Olausson P.  

Reproductive Toxicology, Vol. 17, Iss. 3, 2003-05 ,pp. : 255-261

Elsevier

Access to resources Recommend Favorite

Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease: Guide to Drug Selection

By Graham Jackson  

Drugs, Vol. 64, Iss. 14, 2004-01 ,pp. : 1533-1545

Adis International

Access to resources Recommend Favorite